ATE304592T1 - Automatisierung im proteinentwurf durch proteinbibliotheken - Google Patents
Automatisierung im proteinentwurf durch proteinbibliothekenInfo
- Publication number
- ATE304592T1 ATE304592T1 AT01925092T AT01925092T ATE304592T1 AT E304592 T1 ATE304592 T1 AT E304592T1 AT 01925092 T AT01925092 T AT 01925092T AT 01925092 T AT01925092 T AT 01925092T AT E304592 T1 ATE304592 T1 AT E304592T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- libraries
- automation
- design
- protein design
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18163000P | 2000-02-10 | 2000-02-10 | |
US18690400P | 2000-03-03 | 2000-03-03 | |
US19785100P | 2000-04-14 | 2000-04-14 | |
PCT/US2001/040091 WO2001059066A2 (en) | 2000-02-10 | 2001-02-12 | Protein design automation for protein libraries |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE304592T1 true ATE304592T1 (de) | 2005-09-15 |
Family
ID=27391439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01925092T ATE304592T1 (de) | 2000-02-10 | 2001-02-12 | Automatisierung im proteinentwurf durch proteinbibliotheken |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1255826B1 (de) |
JP (1) | JP2003521933A (de) |
AT (1) | ATE304592T1 (de) |
AU (1) | AU5168701A (de) |
CA (1) | CA2399839A1 (de) |
DE (1) | DE60113381T2 (de) |
DK (1) | DK1255826T3 (de) |
WO (1) | WO2001059066A2 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0974111B1 (de) | 1997-04-11 | 2003-01-08 | California Institute Of Technology | Gerät und verfahren für automatischen protein-entwurf |
US20020048772A1 (en) | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
US6946265B1 (en) | 1999-05-12 | 2005-09-20 | Xencor, Inc. | Nucleic acids and proteins with growth hormone activity |
US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
US7662367B2 (en) | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
US7244823B2 (en) | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
US7351690B2 (en) | 2000-12-19 | 2008-04-01 | Palatin Technologies, Inc. | Knockout identification of target-specific sites in peptides |
JP2005505250A (ja) | 2001-05-04 | 2005-02-24 | ゼンコー | 核酸およびチオレドキシンレダクターゼ活性を有するタンパク質 |
US7381792B2 (en) | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
US7747391B2 (en) | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
US7662925B2 (en) | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US8188231B2 (en) | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
US7317091B2 (en) | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
DK2278509T3 (en) * | 2002-03-01 | 2014-12-15 | Codexis Mayflower Holdings Llc | Methods, systems and software for identification of functional biomolecules |
AU2003231879A1 (en) * | 2002-05-28 | 2003-12-12 | The Trustees Of The University Of Pennsylvania | Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers |
DE10233047A1 (de) * | 2002-07-19 | 2004-02-26 | Amaxa Gmbh | Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein |
US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
US8084582B2 (en) | 2003-03-03 | 2011-12-27 | Xencor, Inc. | Optimized anti-CD20 monoclonal antibodies having Fc variants |
US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
US20090010920A1 (en) | 2003-03-03 | 2009-01-08 | Xencor, Inc. | Fc Variants Having Decreased Affinity for FcyRIIb |
US7587286B2 (en) | 2003-03-31 | 2009-09-08 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7610156B2 (en) | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
US9051373B2 (en) | 2003-05-02 | 2015-06-09 | Xencor, Inc. | Optimized Fc variants |
US9714282B2 (en) | 2003-09-26 | 2017-07-25 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
US8101720B2 (en) | 2004-10-21 | 2012-01-24 | Xencor, Inc. | Immunoglobulin insertions, deletions and substitutions |
EP1697741A4 (de) | 2003-12-04 | 2008-02-13 | Xencor Inc | Verfahren zur erzeugung von proteinvarianten mit erhöhtem wirtsstranggehalt und zusammensetzungen davon |
US20150010550A1 (en) | 2004-07-15 | 2015-01-08 | Xencor, Inc. | OPTIMIZED Fc VARIANTS |
US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
EP2845865A1 (de) | 2004-11-12 | 2015-03-11 | Xencor Inc. | FC-Varianten mit Veränderter Bindung zu FCRN |
US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
JP2008526186A (ja) * | 2005-01-03 | 2008-07-24 | エフ.ホフマン−ラ ロシュ アーゲー | ポリペプチド足場としてのヘモペキシン様構造 |
CA2624189A1 (en) | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
EP1951757B1 (de) | 2005-10-06 | 2014-05-14 | Xencor, Inc. | Optimierte anti-cd30-antikörper |
ES2402591T3 (es) | 2006-08-14 | 2013-05-07 | Xencor Inc. | Anticuerpos optimizados que seleccionan como diana CD19 |
AU2007299843B2 (en) | 2006-09-18 | 2012-03-08 | Xencor, Inc | Optimized antibodies that target HM1.24 |
SG178753A1 (en) | 2007-02-12 | 2012-03-29 | Codexis Inc | Structure-activity relationships |
EP2708557A1 (de) | 2007-05-30 | 2014-03-19 | Xencor, Inc. | Verfahren und Zusammensetzungen zur Hemmung von CD32B-Expressionszellen |
US8633139B2 (en) | 2007-12-21 | 2014-01-21 | Abbvie Biotherapeutics Inc. | Methods of screening complex protein libraries to identify altered properties |
EP3825329A1 (de) | 2007-12-26 | 2021-05-26 | Xencor, Inc. | Fc-varianten mit veränderter bindung zu fcrn |
US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
US20120231969A1 (en) * | 2009-09-25 | 2012-09-13 | Origene Technologies, Inc. | Protein arrays and uses thereof |
US8362210B2 (en) | 2010-01-19 | 2013-01-29 | Xencor, Inc. | Antibody variants with enhanced complement activity |
EP4371570A3 (de) | 2016-06-08 | 2024-07-17 | Xencor, Inc. | Behandlung von erkrankungen im zusammenhang mit igg4 mit anti-cd19-antikörpern mit kreuzbindung an cd32b |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
GB9701425D0 (en) * | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
EP0974111B1 (de) * | 1997-04-11 | 2003-01-08 | California Institute Of Technology | Gerät und verfahren für automatischen protein-entwurf |
WO1999011818A1 (fr) * | 1997-08-28 | 1999-03-11 | Isao Karube | Procede de detection d'acides nucleiques ou de polypeptides hautement fonctionnels |
EP1157093A1 (de) * | 1998-10-16 | 2001-11-28 | Xencor, Inc. | Automatisation im proteindesign durch proteinbanken |
-
2001
- 2001-02-12 EP EP01925092A patent/EP1255826B1/de not_active Expired - Lifetime
- 2001-02-12 CA CA002399839A patent/CA2399839A1/en not_active Abandoned
- 2001-02-12 WO PCT/US2001/040091 patent/WO2001059066A2/en active IP Right Grant
- 2001-02-12 AT AT01925092T patent/ATE304592T1/de not_active IP Right Cessation
- 2001-02-12 JP JP2001558206A patent/JP2003521933A/ja active Pending
- 2001-02-12 AU AU51687/01A patent/AU5168701A/en not_active Abandoned
- 2001-02-12 DE DE60113381T patent/DE60113381T2/de not_active Expired - Lifetime
- 2001-02-12 DK DK01925092T patent/DK1255826T3/da active
Also Published As
Publication number | Publication date |
---|---|
WO2001059066A3 (en) | 2002-04-11 |
DK1255826T3 (da) | 2006-01-30 |
EP1255826B1 (de) | 2005-09-14 |
DE60113381D1 (de) | 2005-10-20 |
AU5168701A (en) | 2001-08-20 |
JP2003521933A (ja) | 2003-07-22 |
EP1255826A2 (de) | 2002-11-13 |
CA2399839A1 (en) | 2001-08-16 |
WO2001059066A2 (en) | 2001-08-16 |
DE60113381T2 (de) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE304592T1 (de) | Automatisierung im proteinentwurf durch proteinbibliotheken | |
WO2000023564A3 (en) | Protein design automation for protein libraries | |
WO2003014325A3 (en) | Protein design automation for protein libraries | |
DE60019458D1 (de) | Stabilisierendes verdünnungsmittel für polypeptide und antigene | |
CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
FR14C0064I2 (fr) | Anticorps anti-il-6, compositions, methodes et utilisations associees | |
SG157952A1 (en) | Small molecule antagonists of bcl-2 family proteins | |
EP1470159A4 (de) | Antikörper gegen latente membranproteine und verwendungen davon | |
TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
RS51635B (sr) | Antitela koja blokiraju cripto i njihova upotreba | |
GB2386224A (en) | Global electronic trading system | |
ATA10002000A (de) | Antigene zusammensetzung | |
ATE398676T2 (de) | Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins | |
NO20033548L (no) | Modifiserte proteiner, designer toksiner og fremgangsmåter for fremstillingav disse | |
DK1084146T3 (da) | Hybridprotein til inhibering af degranuleringen af mastocyter og anvendelse deraf | |
DE602004032573D1 (de) | Stabilisierte zusammensetzungen von faktor-vii-polypeptiden | |
IL176479A0 (en) | Methods and compositions for identifying rna-binding proteins | |
NO20055830D0 (no) | Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme | |
WO2002068453A3 (en) | Methods and compositions for the construction and use of fusion libraries using computational protein design methods | |
EP1482433A3 (de) | Automatisierung von Proteindesign zum Entwerfen von Proteinbibliotheken | |
DE60118935D1 (de) | Dna & protein bindende miniatur proteine | |
WO2004081033A3 (en) | Synthesis of proteins by cell-free protein expression | |
DK1444356T3 (da) | Identifikation af epitoper og mindskelse af allergeniciteten af fødevareproteiner | |
PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
BR0316544A (pt) | Compostos calcilìticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |